A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Urology Oncology Fellowship Bookmark and Share

Urology Oncology Fellowship

The Division of Urology and Urologic Oncology at City of Hope offers one- and two-year Fellowships in Urologic Oncology/Robotic Surgery with special emphasis on minimally invasive and robotic techniques. The one-year program includes one year of clinical work, while the two-year program includes one year of research and one year of clinical work.  Clinical Fellows will have the opportunity to rotate at Huntington Memorial Hospital in Pasadena, in addition to their rotation at City of Hope.
 
City of Hope has had a tradition of training future urologic oncologic surgeons since 1992. Approximately 60 percent of our Fellows go on to careers in the academic setting.
 
Contact:
Clayton S. Lau, M.D.
Director,
Urologic Oncology Fellowship Program 
Division of Urology and Urologic Oncology

City of Hope

1500 East Duarte Road

Duarte, CA 91010-3000 

Phone: 626-256-4673 ext. 60521 

FAX: 626-301-8285
Email: cllau@coh.org
 
A request for additional information may be made to Christina Perez through email christinaperez@coh.org or send to the address above.
 
Eligibility
Candidates must be graduates of an ACGME-accredited urology program. There are currently three to four one-year clinical Fellowship positions available for board eligible/certified urologists. In addition, we have recently expanded the Fellowship and offer two-year Fellowships for those interested in enriching their training in basic science and outcomes research.
The two-year Fellows will spend the first twelve months in a lab working on translational research projects in Urologic Oncology/Robotic Surgery.  The second twelve months will be spent in a clinical Urology service.  During the clinical year, the Fellows participate in over 1,000 laparoscopic/robotic procedures, provide care for in-patients including ICU care, and offer continuity of care in the outpatient clinics.
 
Responsibilities
The Fellow is responsible for all in-patient care and typically operates four days per week with any one of the four current urologic oncology faculty members.  All urologic oncology faculty are Fellowship-trained and members of the Society of Urologic Oncology. The Fellow is currently supported clinically by a nurse practitioner and a physician assistant.
 
Completion of this program also mandates that our Fellows present at national meetings, write research papers, get involved with clinical trials, participate in journal clubs, and present lectures to the oncologic community. Clinical Fellows will have the opportunity to rotate at Huntington Memorial Hospital in Pasadena in addition to their rotation at City of Hope.
 
Based on current occupancy levels, Fellows would be anticipated to participate in the surgical care and management of approximately 800 laparoscopic robotic radical prostatectomies; 75-80 laparoscopic cystoprostatectomies with urinary diversion; and 100-150 laparoscopic and robotic nephrectomies. A variety of other endoscopic, endourologic and general urology cases occur throughout the year.
 

While minimally invasive techniques are an important part of this program, our Fellows are also trained in complex open surgical techniques, such as post-chemotherapy RPLND’s, nephrectomies, open cystectomies and urinary tract reconstructions.  Because our Fellows train in a nationally recognized NCI-designated cancer center, they also have opportunities to participate in many multi-teamed procedures for abdominal and pelvic malignancies. Fellows are also exposed to a multidisciplinary treatment approach to urologic cancers by developing close relationships with radiation oncology, medical oncology, and uropathology.
 
City of Hope has one-year clinical and two-year research/clinical Fellowships available starting July 2016.  Interviews for these positions will be scheduled for January 2015.
 

Application Process

It is best to begin the application process about a year before your anticipated date of entry into the fellowship.
 
Interested parties should contact:
 
Christina Perez
Fellowship Coordinator
Division of Urology and Urologic Oncology
City of Hope
Email: christinaperez@coh.org
Phone: 626.256.4673 ext. 60521
Fax: 626-301-8285

Please note that before an interview date is scheduled, City of Hope must receive:
 
  • Current curriculum vitae,
  • Two letters of reference from faculty in the candidate’s residency-training program
  • Photo
  • Interviews will take place in January of 2015.

Urology Oncology Fellowship

Urology Oncology Fellowship

The Division of Urology and Urologic Oncology at City of Hope offers one- and two-year Fellowships in Urologic Oncology/Robotic Surgery with special emphasis on minimally invasive and robotic techniques. The one-year program includes one year of clinical work, while the two-year program includes one year of research and one year of clinical work.  Clinical Fellows will have the opportunity to rotate at Huntington Memorial Hospital in Pasadena, in addition to their rotation at City of Hope.
 
City of Hope has had a tradition of training future urologic oncologic surgeons since 1992. Approximately 60 percent of our Fellows go on to careers in the academic setting.
 
Contact:
Clayton S. Lau, M.D.
Director,
Urologic Oncology Fellowship Program 
Division of Urology and Urologic Oncology

City of Hope

1500 East Duarte Road

Duarte, CA 91010-3000 

Phone: 626-256-4673 ext. 60521 

FAX: 626-301-8285
Email: cllau@coh.org
 
A request for additional information may be made to Christina Perez through email christinaperez@coh.org or send to the address above.
 
Eligibility
Candidates must be graduates of an ACGME-accredited urology program. There are currently three to four one-year clinical Fellowship positions available for board eligible/certified urologists. In addition, we have recently expanded the Fellowship and offer two-year Fellowships for those interested in enriching their training in basic science and outcomes research.
The two-year Fellows will spend the first twelve months in a lab working on translational research projects in Urologic Oncology/Robotic Surgery.  The second twelve months will be spent in a clinical Urology service.  During the clinical year, the Fellows participate in over 1,000 laparoscopic/robotic procedures, provide care for in-patients including ICU care, and offer continuity of care in the outpatient clinics.
 
Responsibilities
The Fellow is responsible for all in-patient care and typically operates four days per week with any one of the four current urologic oncology faculty members.  All urologic oncology faculty are Fellowship-trained and members of the Society of Urologic Oncology. The Fellow is currently supported clinically by a nurse practitioner and a physician assistant.
 
Completion of this program also mandates that our Fellows present at national meetings, write research papers, get involved with clinical trials, participate in journal clubs, and present lectures to the oncologic community. Clinical Fellows will have the opportunity to rotate at Huntington Memorial Hospital in Pasadena in addition to their rotation at City of Hope.
 
Based on current occupancy levels, Fellows would be anticipated to participate in the surgical care and management of approximately 800 laparoscopic robotic radical prostatectomies; 75-80 laparoscopic cystoprostatectomies with urinary diversion; and 100-150 laparoscopic and robotic nephrectomies. A variety of other endoscopic, endourologic and general urology cases occur throughout the year.
 

While minimally invasive techniques are an important part of this program, our Fellows are also trained in complex open surgical techniques, such as post-chemotherapy RPLND’s, nephrectomies, open cystectomies and urinary tract reconstructions.  Because our Fellows train in a nationally recognized NCI-designated cancer center, they also have opportunities to participate in many multi-teamed procedures for abdominal and pelvic malignancies. Fellows are also exposed to a multidisciplinary treatment approach to urologic cancers by developing close relationships with radiation oncology, medical oncology, and uropathology.
 
City of Hope has one-year clinical and two-year research/clinical Fellowships available starting July 2016.  Interviews for these positions will be scheduled for January 2015.
 

Application Process

Application Process

It is best to begin the application process about a year before your anticipated date of entry into the fellowship.
 
Interested parties should contact:
 
Christina Perez
Fellowship Coordinator
Division of Urology and Urologic Oncology
City of Hope
Email: christinaperez@coh.org
Phone: 626.256.4673 ext. 60521
Fax: 626-301-8285

Please note that before an interview date is scheduled, City of Hope must receive:
 
  • Current curriculum vitae,
  • Two letters of reference from faculty in the candidate’s residency-training program
  • Photo
  • Interviews will take place in January of 2015.
Fellowships and Residencies
City of Hope offers a number of exciting fellowships and residencies in laboratory cancer and diabetes research, administration, clinical applications and other areas.

City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Students and professionals at City of Hope can access a plethora of medical databases, scientific journals, course materials, special collections, and other useful resources at our 12,000 square foot Lee Graff Library.
City of Hope has a long-standing commitment to Continuing Medical Education (CME), sharing advances in cancer research and treatment with the health-care community through CME courses such as conferences, symposia and other on and off campus CME opportunities for medical professionals.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.
NEWS & UPDATES
  • Genetics, genes, genome, genetic risk … Such terms are becoming increasingly familiar to even nonresearchers as studies and information about the human make-up become more extensive and more critical. At City of Hope, these words have long been part of our vocabulary. Researchers and physicians are studyi...
  • Mammograms are currently the best method to detect breast cancer early, when it’s easier to treat and before it’s big enough to feel or cause symptoms. But recent mammogram screening guidelines may have left some women confused about when to undergo annual testing. Here Lusi Tumyan, M.D., chief of t...
  • Although chemotherapy can be effective in treating cancer, it can also exact a heavy toll on a patient’s health. One impressive alternative researchers have found is in the form of a vaccine. A type of immunotherapy, one part of the vaccine primes the body to react strongly against a tumor; the second part dire...
  • The breast cancer statistic is attention-getting: One in eight women will be diagnosed with breast cancer during her lifetime. That doesn’t mean that, if you’re one of eight women at a dinner table, one of you is fated to have breast cancer (read more on that breast cancer statistic), but it does mean that the ...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free. In his first post, ...
  • Advanced age tops the list among breast cancer risk factor for women. Not far behind is family history and genetics. Two City of Hope researchers delving deep into these issues recently received important grants to advance their studies. Arti Hurria, M.D., director of the Cancer and Aging Research Program, and ...
  • City of Hope is extending the reach of its lifesaving mission well beyond U.S. borders. To that end, three distinguished City of Hope leaders visited China earlier this year to lay the foundation for the institution’s new International Medicine Program. The program is part of City of Hope’s strategi...
  • A hallmark of cancer is that it doesn’t always limit itself to a primary location. It spreads. Breast cancer and lung cancer in particular are prone to spread, or metastasize, to the brain. Often the brain metastasis isn’t discovered until years after the initial diagnosis, just when patients were beginning to ...
  • Blueberries, cinnamon, baikal scullcap, grape seed extract (and grape skin extract), mushrooms, barberry, pomegranates … all contain compounds with the potential to treat, or prevent, cancer. Scientists at City of Hope have found tantalizing evidence of this potential and are determined to explore it to t...
  • Most women who are treated for breast cancer with a mastectomy do not choose to undergo reconstructive surgery. The reasons for this, according to a recent JAMA Surgery study, vary. Nearly half say they do not want any additional surgery, while nearly 34 percent say breast cancer reconstruction simply isn’t imp...
  • The leading risk factor for breast cancer is simply being a woman. The second top risk factor is getting older. Obviously, these two factors cannot be controlled, which is why all women should be aware of their risk and how to minimize those risks. Many risk factors can be mitigated, and simple changes can lead...
  • All women are at some risk of developing the disease in their lifetimes, but breast cancer, like other cancers, has a disproportionate effect on minorities. Although white women have the highest incidence of breast cancer, African-American women have the highest breast cancer death rates of all racial and ethni...
  • First, the good news: HIV infections have dropped dramatically over the past 30 years. Doctors, researchers and health officials have made great strides in preventing and treating the disease, turning what was once a death sentence into, for some, a chronic condition. Now, the reality check: HIV is still a worl...
  • Screening for breast cancer has dramatically increased the number of cancers found before they cause symptoms – catching the disease when it is most treatable and curable. Mammograms, however, are not infallible. It’s important to conduct self-exams, and know the signs and symptoms that should be checked by a h...
  • Rob Darakjian was diagnosed with acute lymphoblastic leukemia at just 19 years old. He began chemotherapy and was in and out of the hospital for four months. After his fourth round of treatment, he received a bone marrow transplantation from an anonymous donor. Today, he’s cancer free.   In his previ...